Home Cart 0 Sign in  

[ CAS No. 6212-33-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6212-33-5
Chemical Structure| 6212-33-5
Structure of 6212-33-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6212-33-5 ]

Related Doc. of [ 6212-33-5 ]

Alternatived Products of [ 6212-33-5 ]

Product Details of [ 6212-33-5 ]

CAS No. :6212-33-5 MDL No. :MFCD00049328
Formula : C8H8ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QGJGBYXRJVIYGA-UHFFFAOYSA-N
M.W : 185.61 Pubchem ID :587821
Synonyms :
2-Amino-2-(4-chlorophenyl)acetic acid
Chemical Name :2-Amino-2-(4-chlorophenyl)acetic acid

Calculated chemistry of [ 6212-33-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.7
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.25
Log Po/w (XLOGP3) : -1.07
Log Po/w (WLOGP) : 1.1
Log Po/w (MLOGP) : -0.85
Log Po/w (SILICOS-IT) : 1.17
Consensus Log Po/w : 0.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.55
Solubility : 51.8 mg/ml ; 0.279 mol/l
Class : Very soluble
Log S (Ali) : 0.23
Solubility : 315.0 mg/ml ; 1.7 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -2.08
Solubility : 1.55 mg/ml ; 0.00838 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.72

Safety of [ 6212-33-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6212-33-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6212-33-5 ]
  • Downstream synthetic route of [ 6212-33-5 ]

[ 6212-33-5 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 104-88-1 ]
  • [ 6212-33-5 ]
YieldReaction ConditionsOperation in experiment
34%
Stage #1: With water; ammonium chloride In methanol at 20℃; for 2 h;
Stage #2: With hydrogenchloride In water; toluene for 24 h; Reflux
A solution of 4-chlorobenzaldehyde (4.79 g, 34.08 mmol) inmethanol (10 mL) was added dropwise under vigorous stirring to a solution of KCN (2.48 g, 38.08 mmol) and NH4Cl (2.04 g,38.08 mmol) in water (10 mL). The reaction mixture was vigorously stirred at room temperature for 2 h. Then, water (25 mL) was added and the resulting mixture was extracted with toluene (25 mL). The aqueous layer was discarded and the toluene phase was extracted with 6N aqueous HCl (3 × 10 mL). The combined aqueous phasewas refluxed for 24 h. After that, the reaction mixture was evaporated and the resulting residue was suspended in water. The pHwas adjusted to 6–7 by means of the addition of small portions ofNa2CO3to precipitate the amino acid. The (4-chlorophenyl)glycinewas filtered and dried (2.16 g, 11.62 mmol, 34percent yield) and used inthe next step without further purification. Thionyl chloride (1.79 mL, 24.59 mmol) was added dropwiseto an ice-cooled suspension of (4-chlorophenyl)glycine (2.16 g,11.62 mmol) in dry methanol (29 mL). The resulting solution wasstirred at room temperature for 24 h. Then, the solvent was con-centrated under vacuum and the residue was lyophilized to afforda white solid (2.55 g, 10.80 mmol, 93percent yield). Mp 196–198C (lit.194–197C [10]);1H NMR (D2O, 400 MHz) (, ppm) 7.54–7.50 (m,2H, C6H4), 7.46–7.41 (m, 2H, C6H4), 5.30 (s, 1H, CH), 3.81 (s, 3H,CH3);13C NMR (D2O, 100 MHz) (, ppm) 169.2 (C), 135.9 (C), 129.7(2 x CH), 129.6 (2 x CH), 129.5 (C), 55.7 (CH3), 53.9 (CH); HRMS (ESI-TOF) calc. for [C9H11ClNO2]+requires 200.0473, found 200.0464.
Reference: [1] Journal of Molecular Catalysis A: Chemical, 2017, vol. 426, p. 407 - 418
  • 2
  • [ 32549-33-0 ]
  • [ 6212-33-5 ]
Reference: [1] Patent: CN106380415, 2017, A, . Location in patent: Paragraph 0037; 0038
  • 3
  • [ 1353886-52-8 ]
  • [ 6212-33-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 3, p. 663 - 670
[2] Synthetic Communications, 2012, vol. 42, # 17, p. 2540 - 2554
  • 4
  • [ 7099-88-9 ]
  • [ 6212-33-5 ]
Reference: [1] Chemistry - A European Journal, 2014, vol. 20, # 1, p. 245 - 252
  • 5
  • [ 6212-32-4 ]
  • [ 6212-33-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 1995, vol. 30, # 6, p. 515 - 520
[2] Journal of the Chemical Society, 1962, p. 1440 - 1444
[3] Pharmazie, 1990, vol. 45, # 7, p. 529 - 530
  • 6
  • [ 24091-92-7 ]
  • [ 6212-33-5 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 1, p. 420 - 423
  • 7
  • [ 39546-47-9 ]
  • [ 6212-33-5 ]
Reference: [1] Journal of Organic Chemistry, 1973, vol. 38, p. 2094 - 2096
  • 8
  • [ 104-88-1 ]
  • [ 6212-33-5 ]
Reference: [1] Science China Chemistry, 2013, vol. 56, # 1, p. 117 - 123
  • 9
  • [ 39533-35-2 ]
  • [ 6212-33-5 ]
Reference: [1] Journal of Organic Chemistry, 1973, vol. 38, p. 2094 - 2096
  • 10
  • [ 140-53-4 ]
  • [ 6212-33-5 ]
Reference: [1] Journal of Organic Chemistry, 1966, vol. 31, p. 3708 - 3711
  • 11
  • [ 43189-37-3 ]
  • [ 6212-33-5 ]
Reference: [1] Journal of Organic Chemistry, 1983, vol. 48, # 5, p. 627 - 634
  • 12
  • [ 6212-33-5 ]
  • [ 43189-20-4 ]
Reference: [1] Journal of Molecular Catalysis A: Chemical, 2017, vol. 426, p. 407 - 418
  • 13
  • [ 67-56-1 ]
  • [ 6212-33-5 ]
  • [ 43189-20-4 ]
Reference: [1] Journal of the Chemical Society. Perkin transactions 1, 1976, # 5, p. 475 - 481
  • 14
  • [ 6212-33-5 ]
  • [ 43189-37-3 ]
Reference: [1] Journal of the Chemical Society. Perkin transactions 1, 1976, # 5, p. 475 - 481
  • 15
  • [ 6212-33-5 ]
  • [ 74590-69-5 ]
Reference: [1] Journal of Fluorine Chemistry, 1991, vol. 55, # 2, p. 131 - 136
[2] Journal of Chemical Research, Miniprint, 1995, # 8, p. 1933 - 1945
  • 16
  • [ 24424-99-5 ]
  • [ 6212-33-5 ]
  • [ 147353-95-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 5, p. 2059 - 2073
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6212-33-5 ]

Amino Acid Derivatives

Chemical Structure| 37085-27-1

[ 37085-27-1 ]

(R)-2-Amino-2-(3-chlorophenyl)acetic acid hydrochloride

Similarity: 0.98

Chemical Structure| 7292-71-9

[ 7292-71-9 ]

2-Amino-2-(3-chlorophenyl)acetic acid

Similarity: 0.98

Chemical Structure| 119565-00-3

[ 119565-00-3 ]

(S)-2-Amino-2-(3-chlorophenyl)acetic acid

Similarity: 0.98

Chemical Structure| 1137014-87-9

[ 1137014-87-9 ]

2-Amino-2-(3,5-dichlorophenyl)acetic acid hydrochloride

Similarity: 0.96

Chemical Structure| 141315-50-6

[ 141315-50-6 ]

(S)-2-Amino-2-(2-chlorophenyl)acetic acid

Similarity: 0.92